California Public Employees Retirement System’s Protalix BioTherapeutics PLX Stock Holding History

California Public Employees Retirement System’s Portfolio PLX Stock Details PLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-66,631	Closed	-$297K	–	2566
2021 Q1	$297K	Hold	66,631	–	–	﹤0.01%	3230
2020 Q4	$242K	Hold	66,631	–	–	﹤0.01%	3284
2020 Q3	$258K	Hold	66,631	–	–	﹤0.01%	3160
2020 Q2	$253K	Hold	66,631	–	–	﹤0.01%	3095
2020 Q1	$157K	Sell	66,631 -13,459	-17%	-$44.5K	﹤0.01%	2952
2019 Q4	$263K	Hold	80,090	–	–	﹤0.01%	3011
2019 Q3	$164K	Hold	80,090	–	–	﹤0.01%	2984
2019 Q2	$376K	Hold	80,090	–	–	﹤0.01%	2655
2019 Q1	$352K	Hold	80,090	–	–	﹤0.01%	2710
2018 Q4	$249K	Hold	80,090	–	–	﹤0.01%	2843
2018 Q3	$582K	Hold	80,090	–	–	﹤0.01%	2600
2018 Q2	$344K	Hold	80,090	–	–	﹤0.01%	2790
2018 Q1	$432K	Hold	80,090	–	–	﹤0.01%	2676
2017 Q4	$530K	Hold	80,090	–	–	﹤0.01%	2633
2017 Q3	$465K	Hold	80,090	–	–	﹤0.01%	2694
2017 Q2	$671K	Hold	80,090	–	–	﹤0.01%	2499
2017 Q1	$1.09M	Hold	80,090	–	–	﹤0.01%	2247
2016 Q4	$356K	Hold	80,090	–	–	﹤0.01%	2845
2016 Q3	$449K	Hold	80,090	–	–	﹤0.01%	2765
2016 Q2	$513K	Hold	80,090	–	–	﹤0.01%	2709
2016 Q1	$673K	Hold	80,090	–	–	﹤0.01%	2573
2015 Q4	$817K	Hold	80,090	–	–	﹤0.01%	2512
2015 Q3	$945K	Hold	80,090	–	–	﹤0.01%	2404
2015 Q2	$1.56M	Buy	80,090 +21,310	+36%	+$442K	﹤0.01%	2216
2015 Q1	$1.23M	Hold	58,780	–	–	﹤0.01%	2442
2014 Q4	$1.23M	Buy	58,780 +51,190	+674%	+$1.1M	﹤0.01%	2442
2014 Q3	$184K	Hold	7,590	–	–	﹤0.01%	3427
2014 Q2	$277K	Hold	7,590	–	–	﹤0.01%	3291
2014 Q1	$341K	Hold	7,590	–	–	﹤0.01%	3175
2013 Q4	$297K	Hold	7,590	–	–	﹤0.01%	3179
2013 Q3	$344K	Buy	7,590 +2,640	+53%	+$136K	﹤0.01%	2968
2013 Q2	$243K	Buy	+4,950	New	+$263K	﹤0.01%	3019

Other funds holding PLX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

California Public Employees Retirement System's PLX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Protalix BioTherapeutics (PLX) in Q2 2021, closing a stake of 66,631 shares — an estimated $297K sold.

California Public Employees Retirement System first reported a position in PLX in Q2 2013 and held it in 32 quarters. The position peaked at $1.56M in Q2 2015. 33 funds tracked by Wall St. Rank hold PLX as of Q2 2021.

California Public Employees Retirement System reported no remaining Protalix BioTherapeutics position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 66,631 Protalix BioTherapeutics shares in Q2 2021, an estimated $297K.
California Public Employees Retirement System first reported a position in Protalix BioTherapeutics in Q2 2013 and held it in 32 quarters.
California Public Employees Retirement System's Protalix BioTherapeutics position peaked at $1.56M in Q2 2015.
33 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.